About 23andMe
23andMe is a company based in Sunnyvale (United States) founded in 2006 was acquired by TTAM Research Institute in June 2025. 23andMe has raised $943.53 million across 21 funding rounds from investors including Google, Fidelity Investments and Illumina. The company has 265 employees as of March 31, 2024. 23andMe has completed 2 acquisitions, including CureTogether and Icebreaker Health. 23andMe offers products and services including Ancestry Service, Health + Ancestry Service, and 23andMe Premium. 23andMe operates in a competitive market with competitors including Ancestry, Color, Veritas Genetics, Genoplan and GEDmatch, among others.
- Headquarter Sunnyvale, United States
- Employees 265 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name 23Andme Holding Co.
-
Annual Revenue
$189.9 M (USD)-13.54as on Mar 31, 2024
-
Net Profit
-$280.88 M (USD)57.87as on Mar 31, 2024
-
EBITDA
-$155.85 M (USD)19.44as on Mar 31, 2024
-
Total Equity Funding
$943.53 M (USD)
in 21 rounds
-
Latest Funding Round
$20 M (USD), Post-IPO
Nov 03, 2023
-
Investors
Google
& 20 more
-
Employee Count
265
as on Mar 31, 2024
-
Investments & Acquisitions
CureTogether
& 1 more
-
Acquired by
TTAM Research Institute
(Jun 13, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of 23andMe
23andMe is a publicly listed company on the OTC with ticker symbol MEHCQ in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of 23andMe
23andMe offers a comprehensive portfolio of products and services, including Ancestry Service, Health + Ancestry Service, and 23andMe Premium.
Provides detailed ancestry breakdowns from genetic data.
Offers health insights alongside ancestry reports through genotyping.
Delivers premium reports and features for ongoing genetic health tracking.
People of 23andMe
Unlock access to complete
Unlock access to complete
Funding Insights of 23andMe
23andMe has successfully raised a total of $943.53M across 21 strategic funding rounds. The most recent funding activity was a Post-IPO round of $20 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in 23andMe
23andMe has secured backing from 21 investors, including institutional and venture fund investors. Prominent investors backing the company include Google, Fidelity Investments and Illumina.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sequoia Capital is engaged in venture capital investments.
|
Locked | Locked | Locked | |
|
Venture capital investment firm
|
Locked | Locked | Locked | |
|
Long/short equity hedge fund and VC fim
|
Locked | Locked | Locked |
Investor details for 23andMe
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by 23andMe
23andMe has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include CureTogether and Icebreaker Health.
Investment portfolio details for 23andMe
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of remote patient consultation services and online delivery of medical care products
|
Locked | Locked | 2014 | Locked | |
|
Quantitative data on medical conditions is shared by users online.
|
Locked | Locked | 2008 | Locked |
Complete acquisition details for 23andMe
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - 23andMe
Detailed financials for 23andMe
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
23Andme Comparisons
Peer comparison for 23andMe
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of 23andMe
23andMe operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ancestry, Color, Veritas Genetics, Genoplan and GEDmatch, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of an online genealogy platform offering a host of services
|
|
| Locked | Locked | Locked |
Cancer care is delivered through a virtual clinic by Color.
|
|
| Locked | Locked | Locked |
Genetic testing products for health risks and traits are offered.
|
|
| Locked | Locked | Locked |
Developer of genetic test kits for health analysis
|
|
| Locked | Locked | Locked |
DNA-based health risk assessment platform
|
Detailed competitors of 23andMe
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on 23Andme
Complete news archive for 23andMe
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about 23andMe
23andMe was founded in 2006 and raised its 1st funding round 1 year after it was founded.
23andMe is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
23andMe is a funded company, having raised a total of $943.53M across 21 funding rounds to date.
As of Mar 31, 2024, the latest employee count at 23andMe is 265.
Annual revenue of 23andMe is $189.9M as on Mar 31, 2024.
23andMe was founded in 2006 in Sunnyvale, United States, within the biotechnology sector. Genetic testing services are offered through its platform to analyze individual ancestry, genealogy, and inherited traits. User data is collected, categorized, and supplied in searchable formats to researchers and scientists for further study. Operations focus on direct-to-consumer testing and data aggregation, primarily serving the U.S. market.
23andMe's top competitors include Ancestry, Veritas Genetics and Color.
23andMe offers Ancestry Service, Health + Ancestry Service, and 23andMe Premium.
Yes, 23andMe is publicly traded on OTC under the ticker symbol MEHCQ.
23andMe has made 2 acquisitions, including CureTogether, and Icebreaker Health.
23andMe has 21 investors. Key investors include Google, Fidelity Investments, Illumina, NIH, and HHS.
The ticker symbol of 23andMe is MEHCQ on OTC.